# Antibody Therapy for Enterovirus EV-D68 Infection

> **NIH NIH N01** · HDT BIO CORPORATION · 2020 · $299,959

## Abstract

To develop antibody therapy for Enterovirus EV-D68 infection for use in children.

## Key facts

- **NIH application ID:** 10267598
- **Project number:** 75N93020C00028-0-9999-1
- **Recipient organization:** HDT BIO CORPORATION
- **Principal Investigator:** DARRICK CARTER
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $299,959
- **Award type:** —
- **Project period:** 2020-08-14 → 2021-08-13

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10267598

## Citation

> US National Institutes of Health, RePORTER application 10267598, Antibody Therapy for Enterovirus EV-D68 Infection (75N93020C00028-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10267598. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*